Mass spectrometry-based proteomics: qualitative identification to activity-based protein profiling.
Mass spectrometry has become the method of choice for proteome characterization, including multicomponent protein complexes (typically tens to hundreds of proteins) and total protein expression (up to tens of thousands of proteins), in biological samples. Qualitative sequence assignment based on MS/MS spectra is relatively well-defined, while statistical metrics for relative quantification have not completely stabilized. Nonetheless, proteomics studies have progressed to the point whereby various gene-, pathway-, or network-oriented computational frameworks may be used to place mass spectrometry data into biological context. Despite this progress, the dynamic range of protein expression remains a significant hurdle, and impedes comprehensive proteome analysis. Methods designed to enrich specific protein classes have emerged as an effective means to characterize enzymes or other catalytically active proteins that are otherwise difficult to detect in typical discovery mode proteomics experiments. Collectively, these approaches will facilitate identification of biomarkers and pathways relevant to diagnosis and treatment of human disease.
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
Job D
JD
Cardoza
Jignesh R
JR
Parikh
Scott B
SB
Ficarro
Jarrod A
JA
Marto
D002851:Chromatography, High Pressure Liquid; D006801:Humans; D010748:Phosphopeptides / Q000032:analysis; D060066:Protein Interaction Maps; D011506:Proteins / Q000737:chemistry* / Q000378:metabolism; D020543:Proteome / Q000032:analysis; D040901:Proteomics; D053719:Tandem Mass Spectrometry
D010748:Phosphopeptides; D011506:Proteins; D020543:Proteome